$109.6M in CY2024 Part D spend2.2M claims · 743K beneficiaries · 329 plans surveyed
Questions a plan sponsor actually asks.
What is Solifenacin used for?
Solifenacin succinate tablets are indicated for the treatment of adults with overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency.
Is there a generic for Solifenacin?
Yes. 34 ANDAs filed at FDA, 17 generic manufacturers currently shipping.
How much does my plan pay for Solifenacin?
Across 329 Part D plans, Solifenacin averages $0.174/unit (NADAC). Lowest available: $0.173/unit. Highest in distribution: $0.177/unit.
Is Solifenacin on the FDA shortage list?
No. Solifenacin is not currently on the FDA Drug Shortage Database.
7 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Same class. Different math.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (20 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.